arrow
C

Christian Brandts

Goethe University
H指数:52
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Inhibition of high CXCR4 with Motixafortide and absence of single-cell MRD predict outcome after AML consolidation.

高CXCR4抑制与Motixafortide及单细胞微小残留病缺失预测AML巩固治疗后结局

Blood
IF23.1
2026-04-160
PRE
Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor

多层分子分析为硬化性小圆细胞肿瘤的诊断和靶向治疗提供信息

2026-04-090
OA
Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

开发基于证据、具有成本效益的P4癌症医学,以推动在预防、治疗、患者护理方面的创新,并减少医疗不平等。

2025-12-150
OAAI
Neoadjuvant chemoradiation for patients with resectable locally advanced oral cavity squamous cell carcinoma: Results of the prospective INVERT clinical trial

可切除的局部晚期口腔鳞状细胞癌患者的新辅助放化疗: 前瞻性倒置临床试验的结果

2025-05-010
OA
Head and neck tumor organoid biobank for modelling individual responses to radiation therapy according to the TP53/HPV status

头颈部肿瘤类器官生物样本库,用于根据TP53/HPV状态模拟个体对放射治疗的反应

2025-03-051
OA
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic (vol 149, pg 913, 2022)

德国卓越中心在COVID-19大流行第一年中的癌症护理(vol 149, pg 913, 2022)

2025-01-180
OA
Real-World Comparison of Cabazitaxel Versus 177Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer

真实世界比较:卡巴他赛与177Lu-PSMA放射性药物疗法在转移性去势抵抗性前列腺癌中的应用

2024-11-143
PRE
Value of broad molecular profiling for cancer diagnosis
2023-10-010
OA
Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses
2023-07-2526
OAAI
Profile of the multicenter cohort of the German Cancer Consortium's Clinical Communication Platform

德国癌症联盟临床交流平台多中心队列的概况

2023-04-051
OAAI